fluphenazine has been researched along with Chronic Disease in 151 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 1 year double-blind trial of bromperidol decanoate and fluphenazine decanoate was conducted in the maintenance treatment of 47 outpatients with schizophrenia." | 9.07 | Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates. ( Cookson, JC; McLaren, S; Silverstone, T, 1992) |
| "Eighty hospitalized patients suffering from Schizophrenia or Schizoaffective disorder (male 54, female 26) were first treated with Haloperidol (N=60) or Fluphenazine (N=20), and then were switched to Risperidone." | 5.15 | First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. ( Popović, I; Popović, V; Ravanić, D; Stanojević, A; Stojanović, M; Vladejić, S, 2011) |
| "This study evaluated the feasibility and impact of gradually reducing relatively high doses of fluphenazine decanoate by one-half for chronically impaired, poor inner-city patients with schizophrenia." | 5.07 | A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. ( Egan, GJ; Gloersen, BA; Inderbitzin, LB; Lewine, RR; Scheller-Gilkey, G; Swofford, CD; Vidanagama, BP; Waternaux, C, 1994) |
| "These results do not indicate an association between plasma fluphenazine levels and response to treatment or extrapyramidal side effects in first-episode schizophrenia." | 5.07 | Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients. ( Alvir, J; Chakos, M; Cooper, T; Kane, J; Koreen, AR; Lieberman, J; Loebel, A, 1994) |
| "A 1 year double-blind trial of bromperidol decanoate and fluphenazine decanoate was conducted in the maintenance treatment of 47 outpatients with schizophrenia." | 5.07 | Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates. ( Cookson, JC; McLaren, S; Silverstone, T, 1992) |
| "A double-blind, cross-over trial of the effectiveness of piribedil, procyclidine and placebo in the control of parkinsonism induced by fluphenazine decanoate was conducted in sixteen cases of chronic schizophrenia." | 5.04 | A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. ( Bradley, R; Lamb, P; Mindham, RH, 1977) |
| " This study will present our own experience in the treatment of a pregnant woman suffering from schizophrenia, who was treated with ziprasidone for the duration of her pregnancy." | 3.75 | Pregnancy and atypical antipsychotics. ( Dadić-Hero, E; Knez, R; Medved, P; Petrić, D; Ruzić, K, 2009) |
| " We report the case of a 36 years old woman suffering from chronic schizophrenia and treated with flufenazine and olanzapine, who presented with series of generalised tonic-clonic seizures as the acute onset of recurrent malignant neuroleptic syndrome." | 3.73 | Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report. ( Alvir, D; Kondić, L; Matijević, V; Supe, S, 2006) |
| "This study uses the highly sensitive method of gas chromatography/mass spectrometry to compare the basic steady-state pharmacokinetic parameters of two fluphenazine decanoate formulations." | 2.67 | The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection. ( Brown, WA; Friedhoff, LT; Glazer, WM; Marder, SR, 1992) |
| " The dosage of drugs was varied according to clinical indications." | 2.65 | A comparative trial of the decanoates of flupenthixol and fluphenazine. ( Card, IR; Hamilton, M; Mahmoud, MR; Wallis, GG, 1979) |
| "Relapse was accompanied by a resurgence of specifically schizophrenic symptoms and by an increase in abnormalities described by the relatives." | 2.64 | Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. ( Gaind, R; Hirsch, SR; Rohde, PD; Stevens, BC; Wing, JK, 1973) |
| " This means that it has a long half-life measurable in months rather than weeks." | 1.28 | Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. ( Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG, 1990) |
| "Haloperidol was given to 8 patients for 10 days (group A: 0." | 1.27 | Effects of neuroleptic treatments on peripheral opioid secretion. ( Bellodi, L; Brambilla, F; Brancato, V; Facchinetti, F; Genazzani, AR; Petraglia, F; Smeraldi, E, 1987) |
| "This high rate of relapse is viewed as indicating the need for continued medication in most chronic schizophrenic patients." | 1.26 | Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients. ( Aderounmu, AF; Odejide, OA, 1982) |
| " An individualized approach to the dosage of Fluphenazine decanoate must be practiced in conjunction with, and taking into account the time spent in treatment and the sex and age variables reported." | 1.26 | Drug monitoring at an Australia depot phenothiazine clinic. ( Hiep, A; Marriott, P, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 130 (86.09) | 18.7374 |
| 1990's | 14 (9.27) | 18.2507 |
| 2000's | 6 (3.97) | 29.6817 |
| 2010's | 1 (0.66) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruzić, K | 1 |
| Dadić-Hero, E | 1 |
| Knez, R | 1 |
| Medved, P | 1 |
| Petrić, D | 1 |
| Popović, I | 1 |
| Ravanić, D | 1 |
| Popović, V | 1 |
| Vladejić, S | 1 |
| Stanojević, A | 1 |
| Stojanović, M | 1 |
| SOTELO, D | 1 |
| SMITH, SW | 1 |
| PALMER, B | 1 |
| Buckley, PF | 1 |
| Goldstein, JM | 1 |
| Emsley, RA | 1 |
| Stryjer, R | 1 |
| Grupper, D | 1 |
| Strous, R | 1 |
| Poyurovsky, M | 1 |
| Weizman, A | 1 |
| Supe, S | 1 |
| Matijević, V | 1 |
| Kondić, L | 1 |
| Alvir, D | 1 |
| Baptista, T | 1 |
| Martinez, M | 1 |
| Lacruz, A | 1 |
| Arellano, A | 1 |
| Mendoza, S | 1 |
| Beaulieu, S | 1 |
| Hernández, L | 1 |
| Contreras, Q | 1 |
| Galeazzi, T | 1 |
| Vargas, D | 1 |
| Small, JG | 2 |
| Kellams, J | 1 |
| DeLisi, LE | 1 |
| Wise, CD | 1 |
| Bridge, TP | 1 |
| Rosenblatt, JE | 1 |
| Wagner, RL | 1 |
| Morihisa, J | 1 |
| Karson, C | 1 |
| Potkin, SG | 2 |
| Wyatt, RJ | 1 |
| Baron, M | 2 |
| Gruen, R | 2 |
| Levitt, M | 2 |
| Kane, J | 3 |
| Walker, CA | 1 |
| Johnson, DA | 2 |
| Pasterski, G | 1 |
| Ludlow, JM | 1 |
| Street, K | 1 |
| Taylor, RD | 1 |
| Lapierre, YD | 3 |
| von Frenckell, R | 1 |
| Müller, P | 1 |
| Dencker, SJ | 1 |
| Rivera-Calimlim, L | 1 |
| Hershey, L | 1 |
| Wistedt, B | 2 |
| Ranta, J | 1 |
| Marriott, P | 2 |
| Pansa, M | 1 |
| Hiep, A | 3 |
| Morse, RH | 1 |
| Athanassenas, G | 1 |
| Papadopoulos, E | 1 |
| Kourkoubas, A | 1 |
| Tsitourides, S | 1 |
| Gabriel, J | 1 |
| Hoïdas, S | 1 |
| Frangos, E | 1 |
| McCreadie, RG | 2 |
| Dingwall, JM | 1 |
| Wiles, DH | 2 |
| Heykants, JJ | 1 |
| Odejide, OA | 1 |
| Aderounmu, AF | 1 |
| McCreadie, R | 1 |
| Mackie, M | 1 |
| Morrison, D | 1 |
| Kidd, J | 1 |
| Brent, R | 1 |
| Kalman, T | 1 |
| Filotto, JF | 1 |
| Schooler, NR | 1 |
| Levine, J | 1 |
| Severe, JB | 1 |
| Brauzer, B | 1 |
| DiMascio, A | 1 |
| Klerman, GL | 1 |
| Tuason, VB | 1 |
| Capstick, N | 1 |
| Abuzzahab, FS | 3 |
| Zimmermann, RL | 2 |
| Inderbitzin, LB | 1 |
| Lewine, RR | 1 |
| Scheller-Gilkey, G | 1 |
| Swofford, CD | 1 |
| Egan, GJ | 1 |
| Gloersen, BA | 1 |
| Vidanagama, BP | 1 |
| Waternaux, C | 1 |
| Koreen, AR | 1 |
| Lieberman, J | 1 |
| Alvir, J | 1 |
| Chakos, M | 1 |
| Loebel, A | 1 |
| Cooper, T | 1 |
| Stone, AM | 1 |
| Greenstein, RA | 1 |
| Gamble, G | 2 |
| McLellan, AT | 1 |
| Dhopesh, V | 1 |
| Macfadden, A | 1 |
| Maany, I | 1 |
| Heresco-Levy, U | 1 |
| Greenberg, D | 1 |
| Lerer, B | 1 |
| Javitt, DC | 1 |
| Brown, WA | 3 |
| Moore, DB | 1 |
| Kelly, DL | 1 |
| Sherr, JD | 1 |
| Love, RC | 1 |
| Conley, RR | 1 |
| Al-Sughayir, MA | 1 |
| Davis, JM | 1 |
| Gosenfeld, L | 1 |
| Tsai, CC | 1 |
| McClelland, HA | 1 |
| Farquharson, RG | 1 |
| Leyburn, P | 1 |
| Furness, JA | 1 |
| Schiff, AA | 4 |
| Kellams, JJ | 1 |
| Milstein, V | 1 |
| Klapper, M | 1 |
| Lemberger, L | 1 |
| Devito, RA | 1 |
| Brink, L | 1 |
| Sloan, C | 1 |
| Jolliff, F | 1 |
| Simon, P | 1 |
| Fermanian, J | 1 |
| Ginestet, D | 1 |
| Goujet, MA | 1 |
| Péron-Magnan, P | 1 |
| Misurec, J | 1 |
| Náhunek, K | 1 |
| Svestka, J | 1 |
| Cesková, E | 1 |
| Hamilton, M | 1 |
| Card, IR | 1 |
| Wallis, GG | 1 |
| Mahmoud, MR | 1 |
| Rifkin, A | 2 |
| Quitkin, F | 2 |
| Rabiner, CJ | 1 |
| Klein, DF | 2 |
| Obukhov, GA | 1 |
| Leff, JP | 1 |
| James, NM | 1 |
| Mindham, RH | 1 |
| Lamb, P | 1 |
| Bradley, R | 1 |
| Montgomery, BJ | 1 |
| Fünfgeld, EW | 1 |
| Kulhanek, F | 1 |
| Pinto, R | 1 |
| Bannerjee, A | 1 |
| Ghosh, N | 1 |
| Charalampous, KD | 1 |
| Thornby, J | 1 |
| Ford, BK | 1 |
| Freemesser, GF | 1 |
| Kelly, HB | 1 |
| Freeman, HL | 1 |
| Banning, B | 1 |
| Iqbal, MJ | 1 |
| Young, MA | 1 |
| Charles, J | 1 |
| Elgart, B | 1 |
| Von Greiff, H | 1 |
| Simpson, GM | 2 |
| Owens, D | 1 |
| MacCrimmon, DJ | 1 |
| Saxena, B | 1 |
| Foley, P | 1 |
| Grof, P | 1 |
| Chalmers, RJ | 1 |
| Bennie, EH | 1 |
| Christodoulidis, H | 2 |
| Frangos, H | 1 |
| Lavallee, J | 1 |
| Woggon, B | 1 |
| Angst, J | 2 |
| Margoses, N | 1 |
| Schulz, HD | 1 |
| Kluge, HH | 1 |
| Korda, W | 1 |
| Kube, B | 1 |
| Ayd, FJ | 1 |
| Marriott, PF | 1 |
| Grigor, JM | 1 |
| Itil, TM | 5 |
| Marasa, J | 1 |
| Saletu, B | 3 |
| Davis, S | 1 |
| Mucciardi, AN | 1 |
| Sims, AC | 1 |
| Burnside, IG | 1 |
| Soni, SD | 3 |
| Sampath, G | 1 |
| Shah, A | 1 |
| Krska, J | 1 |
| Glazer, WM | 1 |
| Friedhoff, LT | 1 |
| Marder, SR | 1 |
| McLaren, S | 1 |
| Cookson, JC | 1 |
| Silverstone, T | 1 |
| Seidman, LJ | 1 |
| Pepple, JR | 1 |
| Faraone, SV | 1 |
| Kremen, WS | 1 |
| Cassens, G | 1 |
| McCarley, RW | 1 |
| Tsuang, MT | 1 |
| Samuel, G | 1 |
| Brownlee, M | 1 |
| Yadalam, KG | 1 |
| Levinson, DF | 1 |
| Stephanos, MJ | 1 |
| Lo, ES | 1 |
| Cooper, TB | 1 |
| Costa, J | 1 |
| Khaled, E | 1 |
| Sramek, J | 1 |
| Bunney, W | 1 |
| Lazarus, A | 1 |
| Kolakowska, T | 1 |
| Williams, AO | 1 |
| Ardern, M | 1 |
| Reveley, MA | 1 |
| Brambilla, F | 1 |
| Facchinetti, F | 1 |
| Petraglia, F | 1 |
| Smeraldi, E | 1 |
| Bellodi, L | 1 |
| Brancato, V | 1 |
| Genazzani, AR | 1 |
| Curson, DA | 2 |
| Hirsch, SR | 3 |
| Platt, SD | 2 |
| Bamber, RW | 2 |
| Barnes, TR | 2 |
| Wiles, D | 1 |
| Bamrah, JS | 1 |
| McKane, JP | 1 |
| Robinson, AD | 1 |
| Stirling, GS | 1 |
| Walton, R | 1 |
| Hirschberg, E | 1 |
| Breier, A | 1 |
| Wolkowitz, OM | 1 |
| Doran, AR | 1 |
| Roy, A | 1 |
| Boronow, J | 1 |
| Hommer, DW | 1 |
| Pickar, D | 1 |
| Jayaram, G | 1 |
| Coyle, J | 1 |
| Tune, L | 1 |
| Kong, DS | 1 |
| Yeo, SH | 1 |
| Duffy, JC | 1 |
| Silver, MA | 1 |
| Ahlfors, UG | 1 |
| Whittier, JR | 1 |
| Korenyi, C | 1 |
| Hsu, W | 3 |
| Klingenberg, H | 1 |
| Denham, J | 2 |
| Adamson, L | 2 |
| Roger, BM | 1 |
| Carder, SL | 1 |
| Snibbe, J | 1 |
| Holden, JM | 2 |
| Keskiner, A | 5 |
| Pellet, J | 1 |
| Guyotat, J | 1 |
| Marie-Cardine, M | 1 |
| Dubor, P | 1 |
| Favre-Tissot, M | 1 |
| Caron, F | 1 |
| Cottraux, J | 1 |
| Meltzer, HY | 1 |
| Sachar, EJ | 1 |
| Frantz, AG | 1 |
| Gaind, R | 1 |
| Rohde, PD | 1 |
| Stevens, BC | 1 |
| Wing, JK | 1 |
| Chacon, C | 1 |
| Harper, P | 1 |
| Daniel, GR | 2 |
| Patterson, CD | 1 |
| Winter, K | 1 |
| Fullerton, AG | 1 |
| Hussain, K | 1 |
| Tarlo, L | 1 |
| Frei, M | 1 |
| Bastie, Y | 1 |
| Malm, U | 2 |
| Perris, C | 1 |
| Rapp, W | 1 |
| Wedrén, G | 1 |
| Cesarec, Z | 1 |
| Eberhard, G | 1 |
| Nordgren, L | 1 |
| Gardos, G | 1 |
| Weiser, G | 1 |
| Gattringer, B | 1 |
| Bengesser, G | 1 |
| Jain, RC | 1 |
| Ananth, JV | 1 |
| Klingner, A | 1 |
| Ban, TA | 2 |
| Lehmann, HE | 2 |
| Tsutsul'kovskaia, MIa | 1 |
| Minsker, EI | 1 |
| Panteleeva, GP | 1 |
| Mazurskii, MB | 1 |
| Pekunova, LG | 1 |
| Kelsey, MI | 1 |
| Moscatelli, EA | 1 |
| Friemert, K | 1 |
| Beier, R | 1 |
| Vehreschild, T | 1 |
| Millar, J | 1 |
| Bankier, RG | 1 |
| Pettit, DE | 1 |
| Bergen, B | 1 |
| Hall, WB | 1 |
| Vestre, ND | 1 |
| Schiele, BC | 1 |
| Zimmermann, R | 1 |
| Tetreault, L | 1 |
| Bordeleau, JM | 1 |
| Albert, JM | 1 |
| Rajotte, P | 1 |
| Neal, CD | 1 |
| Imlah, NW | 1 |
| Grosser, HH | 1 |
| Itil, T | 1 |
| Kiremitci, N | 1 |
| Villeneuve, A | 1 |
| Dogan, K | 1 |
| Lachance, R | 1 |
| Proulx, C | 1 |
| Uno, M | 1 |
| Molcan, J | 1 |
| Floreánová, L | 1 |
| Kukucová, H | 1 |
| Motýlová, E | 1 |
| Polák, L | 1 |
| de Groot, MH | 1 |
| Wallace, J | 1 |
| Williams, JR | 1 |
| Solecki, RT | 1 |
| Puttkammer, S | 1 |
| Seeman, M | 2 |
| Turns, D | 2 |
| Denber, HC | 2 |
| Auch, W | 1 |
| Borenstein, P | 1 |
| Dumaine, A | 1 |
| Cujo, P | 1 |
| Kurland, AA | 1 |
| Dim, BH | 1 |
| Olsson, JE | 1 |
| Polvan, N | 1 |
| Young, E | 1 |
| Rasmussen, OS | 1 |
| Deverteuil, R | 1 |
| Saxena, BM | 1 |
| Lambert, PA | 1 |
| Midenet, M | 1 |
| Marcou, G | 1 |
| Bouchardy, M | 1 |
| Pfeiffer, WM | 1 |
| Crane, GE | 1 |
| Graefe, F | 1 |
| Eichstetter, F | 1 |
| Brophy, JJ | 1 |
5 reviews available for fluphenazine and Chronic Disease
| Article | Year |
|---|---|
Neuroleptic concentrations and clinical response.
Topics: Aging; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Drug Interactions; Fluphenazine; Halop | 1984 |
Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Drug Evaluation; Fluphenazine; Humans; Perphe | 1976 |
Maintenance therapy and schizophrenia.
Topics: Acute Disease; Adult; Ambulatory Care; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clinic | 1975 |
[Current status of neuroleptic long term treatment of schizophrenia].
Topics: Ambulatory Care; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Flupenthixol; F | 1975 |
Antipsychotic medication: clinical guidelines for maintenance therapy.
Topics: Administration, Oral; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Dise | 1985 |
64 trials available for fluphenazine and Chronic Disease
| Article | Year |
|---|---|
First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Substitution; F | 2011 |
Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Drug Ad | 2004 |
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Acti | 2007 |
A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Topics: Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Delayed-Action Prepar | 1983 |
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixo | 1983 |
Serum calcium and magnesium levels in chronic schizophrenics.
Topics: Calcium; Chronic Disease; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Loxapine; Magnesiu | 1983 |
Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazi | 1980 |
Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate.
Topics: Adult; Chronic Disease; Double-Blind Method; Female; Fluphenazine; Humans; Male; Psychiatric Status | 1980 |
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Topics: Adult; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Delayed-Action Preparations; Double | 1994 |
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Basal Ganglia Diseases; Chronic Disease; Drug Administ | 1994 |
Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluph | 1997 |
Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; | 1976 |
Effects of lergotrile on schizophrenia & drug induced parkinsonism.
Topics: Acetonitriles; Adult; Antiparkinson Agents; Antipsychotic Agents; Chronic Disease; Clinical Trials a | 1977 |
Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Hum | 1978 |
A comparative trial of the decanoates of flupenthixol and fluphenazine.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Decanoates; Female; Flupenthixol; Fluphenazi | 1979 |
Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year.
Topics: Acute Disease; Administration, Oral; Aftercare; Chronic Disease; Clinical Trials as Topic; Dyskinesi | 1977 |
Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data.
Topics: Administration, Oral; Aftercare; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Fluph | 1977 |
Maintenance therapy and schizophrenia.
Topics: Acute Disease; Adult; Ambulatory Care; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clinic | 1975 |
Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; P | 1977 |
Penfluridol: a double blind trial in chronic schizophrenia.
Topics: Administration, Oral; Adult; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule | 1977 |
A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
Topics: Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Parkinson Disease; Parkinson Diseas | 1977 |
Psychotropic agents finding analgesic use.
Topics: Amitriptyline; Analgesics; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Fluphenazine; | 1978 |
[Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Drug Resistance; Female; Fluphenazine; Human | 1978 |
A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Flupent | 1979 |
Penfluridol versus oral fluphenazine in the maintenance treatment of chronic schizophrenics.
Topics: Administration, Oral; Adult; Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Male; | 1977 |
A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Chronic Disease; Double-Blind Method; Drug Evaluation; Female; Fluphenazine; | 1978 |
Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
Topics: Adult; Ambulatory Care; Chronic Disease; Decanoic Acids; Delayed-Action Preparations; Double-Blind M | 1978 |
A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Middle Aged; Pimozide; Psych | 1976 |
Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Mi | 1975 |
Pimozide and the social behavior of schizophrenics.
Topics: Adolescent; Adult; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Mi | 1975 |
Computerized EEG: predictor of outcome in schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Computers; Drug Resistance; Electroencephalography | 1975 |
Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial.
Topics: Administration, Oral; Chronic Disease; Clinical Trials as Topic; Conditioning, Operant; Fluphenazine | 1975 |
Long-acting phenothiazines for treatment of schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Fluphenazin | 1976 |
The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flup | 1992 |
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
Topics: Adult; Aged; Chronic Disease; Depression; Double-Blind Method; Female; Fluphenazine; Haloperidol; Hu | 1992 |
Psychiatrists and citizens.
Topics: Chronic Disease; Double-Blind Method; Ethics, Medical; Fluphenazine; Humans; Informed Consent; Schiz | 1991 |
Does short term placebo treatment of chronic schizophrenia produce long term harm?
Topics: Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Mi | 1986 |
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; H | 1987 |
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; | 1986 |
Neuroleptic responsivity of negative and positive symptoms in schizophrenia.
Topics: Adult; Brain; Chronic Disease; Dopamine; Double-Blind Method; Female; Fluphenazine; Humans; Male; Pl | 1987 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; | 1985 |
Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine enanthate.
Topics: Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Piperidines; | 1973 |
Clinical observations on the use of a long-acting phenothiazine (fluphenazine enanthate) in chronic schizophrenics.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; S | 1974 |
Effects of fluphenazine hydrochloride on digital computer sleep prints of schizophrenic patients.
Topics: Adult; Analysis of Variance; Chronic Disease; Computers; Electroencephalography; Female; Fluphenazin | 1971 |
Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chronic Disease; Clinical Trials as Topic; Delayed-Action | 1973 |
Clinical and work performance variables in phenothiazine therapy of schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Evalu | 1973 |
Outpatient maintenance of chronic schizophrenics with long-acting fluphenazine.
Topics: Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Fluphenazine; Humans; Placeb | 1973 |
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female; | 1974 |
A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle A | 1973 |
[The depot neuroleptic agent fluspirilene (author's transl)].
Topics: Basal Ganglia Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Female; Fluoroben | 1973 |
[Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Delusions; Drug Evalu | 1974 |
A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
Topics: Adult; Caproates; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evalu | 1974 |
A multicenter multidimensional study of some new longacting neuroleptic drugs.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Attitude of Health Personnel; Caproates; Chroni | 1974 |
A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study.
Topics: Adult; Amphetamine; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Depressi | 1974 |
Are antipsychotic drugs interchangeable?
Topics: Attitude; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, | 1974 |
A trial of fluphenazine enanthate in chronic schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Dosage Forms; Extrapyramidal Tracts; Female; Fluphenazine | 1967 |
A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients.
Topics: Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; Psycholo | 1968 |
A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
Topics: Adult; Aged; Behavior; Chronic Disease; Clinical Trials as Topic; Fluphenazine; Haloperidol; Humans; | 1968 |
[Comparative study of fluphenazine ethanate, fluphenazine bichlorhydrate and placebos in chronic schizophrenics].
Topics: Analysis of Variance; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Delayed-Action Prep | 1969 |
Institutional management of chronic schizophrenics with fluphenazine decanoate.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Tolerance; Fluphenazine; Hospitalization; Humans; Ma | 1970 |
Experience of psychiatric management of schizophrenia with fluphenazine decanoate.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; | 1970 |
Fluphenazine hydrochloride, enanthate, and decanoate in the management of chronic psychosis.
Topics: Administration, Oral; Chronic Disease; Clinical Trials as Topic; Fluphenazine; Hospitalization; Huma | 1970 |
Clinical and quantitative EEG changes at different dosage levels of fluphenazine treatment.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Electroencephalography; Emotions; Female; Fluphena | 1971 |
A controlled study of fluspirilene in chronic schizophrenia.
Topics: Adult; Butylamines; Chronic Disease; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; M | 1970 |
83 other studies available for fluphenazine and Chronic Disease
| Article | Year |
|---|---|
Pregnancy and atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluphenazine; Human | 2009 |
Fluphenazine for chronic psychotic patients.
Topics: Chronic Disease; Fluphenazine; Humans; Mental Disorders; Psychotic Disorders | 1963 |
Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; Fluphenazine; Humans; Male; Middle A | 2004 |
Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Drug Therapy, Combination; Early Diag | 2006 |
Early hospital experience with fluphenazine decanoate.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Fluphenazine; Fo | 1974 |
A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Blood Platelets; Chronic Disease; Depression, Chemical; Female; Fluphen | 1981 |
Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
Topics: Adult; Antipsychotic Agents; Catechol O-Methyltransferase; Chlorpromazine; Chronic Disease; Erythroc | 1982 |
Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Dopamine beta-Hydroxylase; Female; Flu | 1982 |
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Flupenthixol; Fl | 1983 |
AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Female; Fluphenazine; Humans; Male; Middle | 1983 |
[What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Administration Sch | 1983 |
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Biological Availability; Chronic | 1984 |
Intervals between long acting neuroleptics: outcome and re-admission variables.
Topics: Age Factors; Chronic Disease; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Patient Readmis | 1984 |
Chronic pain and the risks of psychotropics.
Topics: Amitriptyline; Chronic Disease; Female; Fluphenazine; Heart Failure; Humans; Meperidine; Middle Aged | 1984 |
Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
Topics: Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Fluphenazine; Humans; Psychiatric | 1982 |
Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Humans; M | 1982 |
Fluphenazine resistant psychosis.
Topics: Chronic Disease; Drug Resistance; Female; Fluphenazine; Humans; Schizophrenia | 1981 |
[Group psychotherapy of chronic schizophrenics in an external milieu].
Topics: Adult; Ambulatory Care; Chronic Disease; Female; Fluphenazine; Humans; Male; Middle Aged; Psychoanal | 1981 |
Long-term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients.
Topics: Adult; Aged; Chronic Disease; Female; Fluphenazine; Humans; Injections; Male; Middle Aged; Schizophr | 1980 |
Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
Topics: Adult; Chronic Disease; Double-Blind Method; Drug Evaluation; Female; Fluphenazine; Humans; Male; Mi | 1980 |
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Ac | 1993 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Flu | 1997 |
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.
Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival | 1998 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utiliz | 2000 |
Fluphenazine decanoate vs oral antipsychotics: a comparison of their effectiveness in the treatment of schizophrenia as measured by a reduction in hospital readmissions.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Female; Fluphe | 1978 |
Computerized EEG in the comparison of oxyprothepin and fluphenazine decanoat.
Topics: Brain; Chronic Disease; Dibenzothiepins; Electroencephalography; Fluphenazine; Humans; Schizophrenia | 1979 |
[Prolonged action neuroleptics (review of the foreign literature)].
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Child; Chronic Diseas | 1975 |
Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Community Mental Health Services; Female; Flupenthixol; Fluphena | 1977 |
Drug monitoring at an Australia depot phenothiazine clinic.
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Australia; Chronic Disease; Decanoates; Delayed-Acti | 1978 |
The use of fluphenazines in a continuing-care program.
Topics: California; Chronic Disease; Continuity of Patient Care; Delayed-Action Preparations; Drug Administr | 1978 |
A controlled study of penfluridol in the treatment of chronic schizophrenia.
Topics: Adult; Ambulatory Care; Chronic Disease; Female; Fluphenazine; Humans; Male; Middle Aged; Penflurido | 1978 |
The effect of fluphenazine on basal prolactin concentrations.
Topics: Adult; Aged; Alcoholism; Chronic Disease; Female; Fluphenazine; Humans; Injections, Intramuscular; M | 1978 |
[Treatment of schizophrenic psychoses with Lyorodin].
Topics: Acute Disease; Chronic Disease; Female; Fluphenazine; Humans; Male; Parkinson Disease, Secondary; Sc | 1977 |
Therapy with injectable fluphenazines.
Topics: Acute Disease; Age Factors; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Delayed-Action | 1976 |
Reducing hospital readmission rates among schizophrenics.
Topics: Adolescent; Adult; Aged; Chronic Disease; Costs and Cost Analysis; Delayed-Action Preparations; Fema | 1976 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, | 1992 |
Wisconsin Card Sorting Test performance over time in schizophrenia. Preliminary evidence from clinical follow-up and neuroleptic reduction studies.
Topics: Activities of Daily Living; Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Dela | 1991 |
Alcohol abuse in chronic schizophrenics: implications for management in the community.
Topics: Adult; Alcohol Drinking; Alcoholism; Chronic Disease; Community Mental Health Services; Delayed-Acti | 1991 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, In | 1990 |
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Glycine; Humans; Male; Psychiatric | 1990 |
Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics.
Topics: Antipsychotic Agents; Benztropine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, | 1985 |
Tardive dyskinesia in schizophrenics under 60 years of age.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Ind | 1986 |
Effects of neuroleptic treatments on peripheral opioid secretion.
Topics: Adult; Antipsychotic Agents; beta-Endorphin; beta-Lipotropin; Chlorpromazine; Chronic Disease; Diben | 1987 |
Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
Topics: Adolescent; Adult; Chronic Disease; Delayed-Action Preparations; Fluphenazine; Humans; Injections, I | 1988 |
More than mere shots.
Topics: Chronic Disease; Communication; Fluphenazine; Haloperidol; Humans; Mental Disorders; Patient Care Te | 1988 |
Long persisting drug-induced parkinsonism--a case report.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Parkinson Disease | 1987 |
Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chronic Disease; Female; Fluphenazine; Humans; Injections, | 1986 |
Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; | 1985 |
Effect of oral fluphenazine on Huntington's chorea.
Topics: Age Factors; Aged; Chronic Disease; Female; Fluphenazine; Humans; Huntington Disease; Male; Mental P | 1968 |
The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aftercare; Aged; Chronic Disease; Delayed-Action Preparatio | 1971 |
[Evaluation of fluphenazine use since establishment of a psychiatric section].
Topics: Administration, Oral; Adolescent; Adult; Aftercare; Chronic Disease; Delayed-Action Preparations; De | 1972 |
Long-acting phenothiazines in the prevention of relapse of schizophrenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aftercare; Aged; Chronic Disease; Comprehensive Health Care | 1973 |
Outpatient management of chronic schizophrenics with fluphenazine enanthate (Prolixin enanthate): a clinical evaluation.
Topics: Adult; Aftercare; Ambulatory Care; Chronic Disease; Evaluation Studies as Topic; Female; Fluphenazin | 1973 |
Predictor patterns in the management of therapy-resistant schizophrenia.
Topics: Adult; Age Factors; Chronic Disease; Disability Evaluation; Female; Fluphenazine; Hospitalization; H | 1971 |
[Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Topics: Alcoholism; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine | 1972 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |
[Neuroleptic depot treatment of chronic psychoses with fluphenazine-dekanoate].
Topics: Adolescent; Adult; Aged; Alcoholism; Chronic Disease; Fluphenazine; Humans; Male; Middle Aged; Schiz | 1973 |
Uncontrolled study with pipothiazine palmitate.
Topics: Adult; Chemical Phenomena; Chemistry; Chronic Disease; Female; Fluphenazine; Humans; Male; Middle Ag | 1973 |
[Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Topics: Adult; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Hum | 1973 |
Gas-liquid chromatographic analysis of fluphenazine and fluphenazine sulfoxide in the urine of chronic schizophrenic patients.
Topics: Animals; Chromatography, Gas; Chronic Disease; Estrus; Female; Fluphenazine; Humans; Methods; Pregna | 1973 |
[Results of therapy with Lyogen-Depot in schizophrenic diseases].
Topics: Administration, Oral; Chronic Disease; Delayed-Action Preparations; Drug Evaluation; Female; Fluphen | 1974 |
Side effects of phenothiazines.
Topics: Chronic Disease; Fluphenazine; Humans; Paranoid Disorders; Schizophrenia | 1972 |
[Follow-up studies of schizophrenia].
Topics: Adult; Catalepsy; Catatonia; Chlorpromazine; Chronic Disease; Convulsive Therapy; Depersonalization; | 1971 |
Therapeutic effect of fluphenazin in various doses and forms.
Topics: Chronic Disease; Dosage Forms; Fluphenazine; Humans; Injections; Liver Function Tests; Movement Diso | 1971 |
Fluphenazine: a retrospective assessment in 130 patients with residual schizophrenia.
Topics: Adult; Age Factors; Aged; Chronic Disease; Fluphenazine; Hospitalization; Humans; Male; Middle Aged; | 1970 |
Effects of single, combined, and non-drug treatments on chronic mental patients. (A preliminary study).
Topics: Aged; Analysis of Variance; Behavior; Brain Damage, Chronic; Chronic Disease; Drug Synergism; Fluphe | 1969 |
[Multiple therapeutic approaches and their effects on chronicity: case report].
Topics: Adolescent; Adult; Automatism; Chlorpromazine; Chronic Disease; Electroconvulsive Therapy; Female; F | 1969 |
[Multiple therapeutic approaches and their effects on chronicity: case report].
Topics: Adolescent; Adult; Automatism; Chlorpromazine; Chronic Disease; Electroconvulsive Therapy; Female; F | 1969 |
[The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Delayed-Action Preparations; Fluphenazine; Humans; | 1970 |
[Clinical and biological effects of fluphénazine décanoate. 35 cases].
Topics: Anxiety; Blood Pressure; Chronic Disease; Extrapyramidal Tracts; Fluphenazine; Humans; Psychotic Dis | 1970 |
The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
Topics: Administration, Oral; Adult; Biperiden; Chronic Disease; Female; Fluphenazine; Humans; Infusions, Pa | 1970 |
Fluphenazine hydrochloride and enanthate in the management of chronic psychosis.
Topics: Chronic Disease; Extrapyramidal Tracts; Fluphenazine; Humans; Schizophrenia | 1970 |
Hospital experience with fluphenazine enanthate.
Topics: Chronic Disease; Fluphenazine; Humans; Injections, Intramuscular; Intellectual Disability; Schizophr | 1970 |
Intramuscular long-acting fluphenazine in the treatment of schizophrenia.
Topics: Administration, Oral; Adult; Aged; Chlorpromazine; Chronic Disease; Fluphenazine; Haloperidol; Human | 1970 |
Fluphenazine enanthate in sesame oil, a depot preparation.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Huma | 1970 |
Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
Topics: Adult; Aged; Chronic Disease; Female; Fluphenazine; Humans; Injections, Subcutaneous; Male; Middle A | 1971 |
[Fluphenazine enanthate, delayed-action neuroleptic dru utilizable in outpatients treatment of chronic psychosis].
Topics: Ambulatory Care; Chronic Disease; Fluphenazine; Humans; Injections, Intramuscular; Psychotic Disorde | 1967 |
[Clinical therapeutic experiences with fluphenazine].
Topics: Acute Disease; Arteriosclerosis; Bipolar Disorder; Catatonia; Chronic Disease; Dementia; Depressive | 1967 |
Dyskinesia and neuroleptics.
Topics: Adult; Chlorpromazine; Chronic Disease; Fluphenazine; Hospitalization; Humans; Male; Middle Aged; Mo | 1968 |
[New approach to the long-term management of chronic psychoses].
Topics: Age Factors; Anticonvulsants; Chronic Disease; Extrapyramidal Tracts; Female; Fluphenazine; Humans; | 1968 |
[Experience in the management of chronic psychoses using fluphenazine-oenanthate].
Topics: Adolescent; Adult; Chronic Disease; Epilepsy; Female; Fluphenazine; Humans; Injections, Intramuscula | 1968 |
Single daily doses of neuroleptic drugs.
Topics: Chlorpromazine; Chlorprothixene; Chronic Disease; Dosage Forms; Fluphenazine; Haloperidol; Humans; M | 1969 |